a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with VIR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then VIR could also see price increases.
Ticker / NAME | Correlation To CNSP | 1D Price Change % | ||
---|---|---|---|---|
CNSP | 100% | +9.93% | ||
VIR - CNSP | 36% Loosely correlated | +2.81% | ||
AAVXF - CNSP | 34% Loosely correlated | N/A | ||
PTGX - CNSP | 30% Poorly correlated | +0.58% | ||
HOWL - CNSP | 26% Poorly correlated | -4.35% | ||
NRIX - CNSP | 26% Poorly correlated | +2.93% | ||
More |